← Leaderboards
Venu Raman
Johns Hopkins University
$6,874,952
Attributed
$6,874,952
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $652.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,874,952 · 6
By mechanism
R01$6,131,450 · 4
R21$399,129 · 1
P50$344,373 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Zaver M Bhujwalla$35,375,851
- Kristine Glunde$12,806,818
- Ben H Park$14,510,999
- Alison P Klein$15,423,583
- Saeed Rehman Khan$1,441,162
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LinePathway InteractionsMolecularBreastSamplingMalignant NeoplasmsProgramsBaseBreast Cancer CellPre-Clinical ModelMalignant Breast NeoplasmCellsExhibitsPharmaceutical PreparationsOrganIn VivoNeoplasm MetastasisPhenotypeAutopsyGrowthVisceralMammary NeoplasmsMammary GlandDesign
Grant awards (25)
Targeting DDX3 for triple-negative breast cancer treatment$399,129
R21 · FY2025 · CA · contact PI
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression$370,575
R01 · FY2020 · CA · contact PI
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression$359,457
R01 · FY2019 · CA · contact PI
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression$370,575
R01 · FY2018 · CA · contact PI
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression$370,575
R01 · FY2017 · CA · contact PI
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression$370,575
R01 · FY2016 · CA · contact PI
The role of Twist in inducing breast cancer initiating cells and metastasis$235,451
R01 · FY2015 · CA · contact PI
MOLECULAR ONCOLOGY RESOURCE$87,593
P50 · FY2015 · CA · contact PI
Functional Imaging of Twist induced breast cancer$320,189
R01 · FY2014 · CA · contact PI
The role of Twist in inducing breast cancer initiating cells and metastasis$232,057
R01 · FY2014 · CA · contact PI
MOLECULAR ONCOLOGY RESOURCE$84,916
P50 · FY2014 · CA · contact PI
Functional Imaging of Twist induced breast cancer$310,286
R01 · FY2013 · CA · contact PI
The role of Twist in inducing breast cancer initiating cells and metastasis$225,065
R01 · FY2013 · CA · contact PI
Molecular Pathology Resource$88,542
P50 · FY2013 · CA · contact PI
Functional Imaging of Twist induced breast cancer$330,091
R01 · FY2012 · CA · contact PI
The role of Twist in inducing breast cancer initiating cells and metastasis$239,352
R01 · FY2012 · CA · contact PI
Molecular Pathology Resource$83,322
P50 · FY2012 · CA · contact PI
Functional Imaging of Twist induced breast cancer$330,091
R01 · FY2011 · CA · contact PI
The role of Twist in inducing breast cancer initiating cells and metastasis$233,878
R01 · FY2011 · CA · contact PI
Functional Imaging of Twist induced breast cancer$334,988
R01 · FY2010 · CA · contact PI
The Role of HOXA5 in Breast Cancer$286,025
R01 · FY2008 · CA · contact PI
The Role of HOXA5 in Breast Cancer$286,025
R01 · FY2007 · CA · contact PI
The Role of HOXA5 in Breast Cancer$294,569
R01 · FY2006 · CA · contact PI
The Role of HOXA5 in Breast Cancer$301,658
R01 · FY2005 · CA
The Role of HOXA5 in Breast Cancer$329,968
R01 · FY2004 · CA